Humalog 100IU/ml Kwikpen
Marketer
Eli Lilly and Company India Pvt Ltd
Salt Composition
Insulin Lispro (100IU)
Overview Humalog 100IU/ml Kwikpen
NovoLog 100 IU/mL FlexPen aids in managing blood glucose in individuals with type 1 and type 2 diabetes. This rapid-acting insulin lowers post-meal blood sugar, mitigating the risk of diabetic complications. NovoLog 100 IU/mL FlexPen is typically administered alongside a long-acting insulin or other anti-diabetic medications. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Injection should occur 15 minutes prior to, or within 20 minutes of, meal commencement. Discontinue use only under physician guidance. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Consistent blood glucose monitoring and result tracking, shared with your physician, is crucial for optimal dosage determination. Hypoglycemia is the most frequent adverse event. Precise dosing, regular blood glucose monitoring, and consistent meal timing are vital for its prevention. Excessive alcohol consumption may also induce hypoglycemia. Additional side effects may include injection site reactions such as redness, swelling, or lipodystrophy. Weight gain is also possible. Avoid using this medication if you have hypoglycemia. Prior to treatment initiation, inform your doctor of any existing kidney, liver, or heart conditions. Pregnant or lactating individuals require physician consultation for potential dosage adjustments.
Primary Ingredients of Humalog 100IU/ml Kwikpen
The provided text is "undefined," so there is nothing to rephrase.
Uses of Humalog 100IU/ml Kwikpen
Managing Diabetic Conditions
Major Benefits of Humalog 100IU/ml Kwikpen:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Humalog 100IU/ml Kwikpen:
- Hypoglycemia (low blood glucose level)
How to use Humalog 100IU/ml Kwikpen:
Your healthcare provider will instruct you on the proper administration of this medication.
How Humalog 100IU/ml Kwikpen works:
Lispro insulin (100 IU/mL) in the KwikPen delivery system provides rapid-onset glucose control, typically beginning within 10 to 20 minutes of subcutaneous administration. Its action mimics endogenous insulin, promoting glucose uptake into muscle and adipose tissue while simultaneously suppressing hepatic glucose production.
SAFETY ADVICE
AlcoholUNSAFE
Combining Humalog 100IU/ml Kwikpen and alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Humalog 100 IU/ml KwikPen during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data from human trials, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Humalog 100 IU/ml Kwikpen. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms appear.
KidneyCAUTION
Individuals with kidney impairment should use Humalog 100 IU/ml KwikPen cautiously. Dosage modification of Humalog 100 IU/ml KwikPen may be necessary. Physician consultation is recommended. Regular blood glucose level checks are essential for appropriate dose management.
LiverCAUTION
Individuals with liver impairment should use the Humalog 100 IU/ml KwikPen cautiously. Dosage modifications may be necessary for this patient group. Physician consultation is recommended. Close, consistent blood glucose monitoring is advisable to guide appropriate dosage changes.
What if you forget to take Humalog 100IU/ml Kwikpen :
Failure to administer a scheduled dose of Humalog 100 IU/ml KwikPen can lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar and adjust your subsequent injection accordingly.
Facts to Know About Humalog 100IU/ml Kwikpen
| Label | Value |
|---|---|
| Chemical Type | Insulin analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Actions | Fast-acting insulin analogs |



